Scholarship for bachelor and master students to perform research

The Institute of Advanced Chemistry of Catalonia (IQAC-CSIC) offers up to 19 scholarships to bachelor's and Master’s degree for the introduction to a research career with a duration from 5 to 10 months, a salary of 600 € per month and an…

Post-graduate / PhD opportunity in Medicinal Chemistry and Chemical Biology

The Medicinal Chemistry and Synthesis research group (MCS) at the Institute for Advanced Chemistry of Catalonia (IQAC-CSIC) is offering a postgraduate fellowship for a duration of 5 to 7 months (€600/month), with the possibility of applying…

IQAC-CSIC’s Commitment to Rare Disease Research

A disease is considered to be rare when it affects 5 people per 10,000, a small number of people compared to the general population. Currently, there are more than 7,000 rare diseases described, affecting 300 million people in the world, and…

Dirección del IQAC-CSIC

Plazo de presentación de candidaturas: 1 mes natural desde la presente publicación (hasta el 13 de marzo 2025). Presentación de la documentación: en un único correo electrónico en la dirección gerencia@cid.csic.es. Requisitos: Ser…

The different research projects at IQAC-CSIC for tumour treatment

In the frame of World Cancer Day, held on 4th February, various research projects at the Institute for Advanced Chemistry of Catalonia (IQAC-CSIC) stand out for their efforts to find new therapeutic solutions for treating aggressive tumours.…

“Bojos per la Satut Global” begins, an excellence program by Fundació Catalunya la Pedrera

The 13th edition of "Bojos per la Ciència" (“Crazy about Science”), the excellence program aimed at high school students with a strong interest in science, technology, and research, celebrated the inauguration of the 2025 course on January…

The Medicinal Chemistry and Synthesis group joins the Xartec Salut network

The IQAC-CSIC research group Medicinal Chemistry and Synthesis has joined the Xartec Salut network, bringing cutting-edge expertise in chemical research, advancing knowledge and therapeutic technologies. This incorporation will allow the…

A hyperthermia therapy using magnetic nanoparticles proposed to enhance the treatment of pancreatic cancer with adenocarcinoma

A preclinical study led by the Vall d'Hebron Institute of Research (VHIR), in collaboration with the Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), has proposed the use of magnetic nanoparticles and hyperthermia to improve the…

A chemical compound that reduces breast cancer metastasis is tested on mice

Breast cancer is the most common cancer in women, and one of the deadliest forms is metastatic triple-negative breast cancer. This type affects the functioning of macrophages, key components of the immune system that, under normal conditions,…

A new therapy paves the way for the treatment of Fabry disease

An international research team led by the Institute of Materials Science of Barcelona (ICMAB-CSIC) and CIBER-BBN, with the collaboration of the Institute for Advanced Chemistry of Catalonia (IQAC-CSIC),  has developed a new therapy based…